CareLit Fachartikel

Role of RAGE and its ligands S100A8/A9 in hepatocellular carcinoma onset and development

AM De Ponti, D Schneller, T Pusterla, L Wiechert, T Longerich, S Marhenke, P Schirmacher, A Vogel, E Pikarsky, J Hess, P Angel · Zeitschrift für Gastroenterologie · 2015 · Heft 01

Dokument
1114329
CareLit-ID
Jahr
2015
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
AM De Ponti, D Schneller, T Pusterla, L Wiechert, T Longerich, S Marhenke, P Schirmacher, A Vogel, E Pikarsky, J Hess, P Angel
Ausgabe
Heft 01 / 2015
Seiten
–
Erschienen: 2015-01-16 00:00:00
ISSN
0044-2771

Zusammenfassung

The Receptor for Advanced Glycation-End products (RAGE) is a multi-ligand receptor, mainly involved in tissue damage and inflammatory disorders. RAGE and its ligands S100A8 and S100A9 have been shown to be overexpressed in tumors, including hepatocellular carcinoma (HCC), enhancing cancer progression and metastasis by still unknown mechanisms. To address the role played by RAGE and S100A8/A9 in HCC onset and development, we took advantage of two mouse models: (i) the multidrug resistance 2 knock-out (Mdr2-/-) mouse and (ii) treatment with the procarcinogen diethylnitrosamine (DEN). The Mdr2-/- mouse shows chroni…

Schlagworte

Receptor for Advanced Glycation End Products Diethylnitrosamine Address Affect Hepatitis Tumor Zeitschrift für Gastroenterologie